Education
About Us
Working with TipRanks
Follow Us
China SXT Pharmaceuticals Inc (SXTC)
NASDAQ:SXTC
SXTC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.95 - $11.92
Previous CloseN/A
Volume317.99K
Average Volume (3M)1.09M
Market Cap
$199.57M
Enterprise Value-$11.72M
Total Cash (Recent Filing)$12.07M
Total Debt (Recent Filing)$2.65M
Price to Earnings (P/E)<0.1
Beta0.65
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.73
Shares Outstanding116,027,756
10 Day Avg. Volume92,017
30 Day Avg. Volume1,087,424
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.13
Price to Sales (P/S)0.00
P/FCF Ratio-12.50
Enterprise Value/Market Cap-0.06
Enterprise Value/Revenue-1.12
Enterprise Value/Gross Profit-19.68
Enterprise Value/Ebitda0.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
China SXT Pharmaceuticals News
PremiumCompany Announcements
China SXT Pharmaceuticals Issues 90 Million Shares Following Warrant Exercise
PremiumCompany Announcements
China SXT Pharmaceuticals Completes Share Sale Agreement
PremiumMarket News
3 Penny Stocks to Watch Now, 4/22/25
PremiumCompany Announcements
China SXT Pharmaceuticals Optimizes Capital Structure with Warrant Exchange
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
0.44% Other Institutional Investors
100.00% Public Companies and
Individual Investors
SXTC FAQ
What was China SXT Pharmaceuticals Inc’s price range in the past 12 months?
China SXT Pharmaceuticals Inc lowest stock price was $0.95 and its highest was $11.92 in the past 12 months.
What is China SXT Pharmaceuticals Inc’s market cap?
China SXT Pharmaceuticals Inc’s market cap is $199.57M.
When is China SXT Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were China SXT Pharmaceuticals Inc’s earnings last quarter?
China SXT Pharmaceuticals Inc released its earnings results on Mar 28, 2019. The company reported $3.29 earnings per share for the quarter, beating the consensus estimate of N/A by $3.29.
Is China SXT Pharmaceuticals Inc overvalued?
According to Wall Street analysts China SXT Pharmaceuticals Inc’s price is currently Overvalued.
Does China SXT Pharmaceuticals Inc pay dividends?
China SXT Pharmaceuticals Inc does not currently pay dividends.
What is China SXT Pharmaceuticals Inc’s EPS estimate?
China SXT Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China SXT Pharmaceuticals Inc have?
China SXT Pharmaceuticals Inc has 116,027,756 shares outstanding.
What happened to China SXT Pharmaceuticals Inc’s price movement after its last earnings report?
China SXT Pharmaceuticals Inc reported an EPS of $3.29 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of China SXT Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in SXTC
China SXT Pharmaceuticals Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 4.2%
Last 30 Days ▼ 4.2%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-80.63%
12-Months-Change
Fundamentals
Return on Equity
57.63%
Trailing 12-Months
Asset Growth
112.49%
Trailing 12-Months
Company Description
China SXT Pharmaceuticals Inc
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.